AllSquare Wealth Management’s Beam Therapeutics BEAM Stock Holding History

AllSquare Wealth Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.91K	Hold	120	–	–	﹤0.01%	451
2025 Q2	$2.04K	Hold	120	–	–	﹤0.01%	468
2025 Q1	$2.34K	Hold	120	–	–	﹤0.01%	466
2024 Q4	$2.98K	Hold	120	–	–	﹤0.01%	451
2024 Q3	$2.94K	Hold	120	–	–	﹤0.01%	454
2024 Q2	$2.81K	Hold	120	–	–	﹤0.01%	450
2024 Q1	$3.96K	Hold	120	–	–	﹤0.01%	436
2023 Q4	$3.27K	Hold	120	–	–	﹤0.01%	447
2023 Q3	$2.89K	Sell	120 -440	-79%	-$11.8K	﹤0.01%	454
2023 Q2	$17.9K	Hold	560	–	–	0.01%	311
2023 Q1	$17.1K	Hold	560	–	–	0.01%	316
2022 Q4	$21.9K	Hold	560	–	–	0.02%	279
2022 Q3	$27K	Hold	560	–	–	0.02%	253
2022 Q2	$22K	Hold	560	–	–	0.02%	279
2022 Q1	$32K	Hold	560	–	–	0.02%	265
2021 Q4	$45K	Hold	560	–	–	0.03%	231
2021 Q3	$49K	Sell	560 -100	-15%	-$10K	0.03%	225
2021 Q2	$85K	Sell	660 -100	-13%	-$7.97K	0.05%	178
2021 Q1	$61K	Buy	+760	New	+$72.3K	0.04%	196

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AllSquare Wealth Management's BEAM Position: Q3 2025 in Review

AllSquare Wealth Management held its Beam Therapeutics (BEAM) position steady in Q3 2025 at 120 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

AllSquare Wealth Management first reported a position in BEAM in Q1 2021 and has held it in 19 quarters since. The position peaked at $85K in Q2 2021. 218 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

AllSquare Wealth Management held 120 shares of Beam Therapeutics worth $2.91K as of Q3 2025.
AllSquare Wealth Management left its Beam Therapeutics share count unchanged in Q3 2025.
Beam Therapeutics made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #451 holding.
AllSquare Wealth Management first reported a position in Beam Therapeutics in Q1 2021 and has held it in 19 quarters since.
AllSquare Wealth Management's Beam Therapeutics position peaked at $85K in Q2 2021.
218 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.